Literature DB >> 1769942

Lactate dehydrogenase activity as a cause of metronidazole resistance in Bacteroides fragilis NCTC 11295.

S Narikawa1, T Suzuki, M Yamamoto, M Nakamura.   

Abstract

Enzymes acting on pyruvate as a parameter of the ATP regeneration system were studied as a cause of metronidazole resistance in Bacteroides fragilis NCTC 11295. The resistant strain had higher lactate dehydrogenase activity and produced more lactate than susceptible strains, suggesting that the enzyme is more active in lactic acid fermentation. Furthermore, the reaction catalysed by lactate dehydrogenase occurred up to 48 mg/L metronidazole, whereas the reaction catalysed by pyruvate: ferredoxin oxidoreductase reaction stopped at 2 mg/L. The mechanism of metronidazole resistance in B. fragilis NCTC 11295 may be due to the high activity of lactate dehydrogenase which compensates for the decreased activity of pyruvate: ferredoxin oxidoreductase in the presence of metronidazole.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1769942     DOI: 10.1093/jac/28.1.47

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  10 in total

1.  Comparative In vitro activities of ertapenem (MK-0826) against 1,001 anaerobes isolated from human intra-abdominal infections.

Authors:  E J Goldstein; D M Citron; C Vreni Merriam; Y Warren; K L Tyrrell
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

2.  National hospital survey of anaerobic culture and susceptibility testing methods: results and recommendations for improvement.

Authors:  E J Goldstein; D M Citron; R J Goldman
Journal:  J Clin Microbiol       Date:  1992-06       Impact factor: 5.948

3.  Bacteremia caused by a metronidazole-resistant Prevotella sp. strain.

Authors:  Francine Mory; Jean-Philippe Carlier; Corentine Alauzet; Maxime Thouvenin; Hélène Schuhmacher; Alain Lozniewski
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

4.  Metabolic activities of metronidazole-sensitive and -resistant strains of Helicobacter pylori: repression of pyruvate oxidoreductase and expression of isocitrate lyase activity correlate with resistance.

Authors:  P S Hoffman; A Goodwin; J Johnsen; K Magee; S J Veldhuyzen van Zanten
Journal:  J Bacteriol       Date:  1996-08       Impact factor: 3.490

5.  Comparative in vitro activities of ertapenem (MK-0826) against 469 less frequently identified anaerobes isolated from human infections.

Authors:  Ellie J C Goldstein; Diane M Citron; C Vreni Merriam; Yumi A Warren; Kerin L Tyrrell; Helen Fernandez
Journal:  Antimicrob Agents Chemother       Date:  2002-04       Impact factor: 5.191

6.  Modulation of Iron Import and Metronidazole Resistance in Bacteroides fragilis Harboring a nimA Gene.

Authors:  Ana Paunkov; József Sóki; David Leitsch
Journal:  Front Microbiol       Date:  2022-06-09       Impact factor: 6.064

7.  Isolation of metronidazole-resistant Bacteroides fragilis carrying the nimA nitroreductase gene from a patient in Washington State.

Authors:  Jeffrey M Schapiro; Rachna Gupta; Eric Stefansson; Ferric C Fang; Ajit P Limaye
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

8.  Exploratory Investigation of Bacteroides fragilis Transcriptional Response during In vitro Exposure to Subinhibitory Concentration of Metronidazole.

Authors:  Michele C R de Freitas; Juliana A Resende; Alessandra B Ferreira-Machado; Guadalupe D R Q Saji; Ana T R de Vasconcelos; Vânia L da Silva; Marisa F Nicolás; Cláudio G Diniz
Journal:  Front Microbiol       Date:  2016-09-20       Impact factor: 5.640

9.  Overexpression of the rhamnose catabolism regulatory protein, RhaR: a novel mechanism for metronidazole resistance in Bacteroides thetaiotaomicron.

Authors:  Ekta H Patel; Lynthia V Paul; Ana I Casanueva; Sheila Patrick; Valerie R Abratt
Journal:  J Antimicrob Chemother       Date:  2009-06-13       Impact factor: 5.790

Review 10.  Clinical review: bacteremia caused by anaerobic bacteria in children.

Authors:  Itzhak Brook
Journal:  Crit Care       Date:  2002-05-09       Impact factor: 9.097

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.